Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-18T16:02:22.961Z Has data issue: false hasContentIssue false

“Stemetil” in the Treatment of Chronic Psychotics

Published online by Cambridge University Press:  08 February 2018

A. J. Galbraith
Affiliation:
Knowle Hospital, Fareham, Hants
J. K. Hewat
Affiliation:
Knowle Hospital, Fareham, Hants
D. MacNamara
Affiliation:
Knowle Hospital, Fareham, Hants

Extract

The range of Phenothiazine tranquillizers continues to expand. Among more recent introductions is prochlorperazine (“Stemetil”) which incorporates a piperazine ring in the side chain.

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1959 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Borel, et al., “Therapeutic trials with two phenothiazine derivatives, 4632 RP (Mopazine) and 6140 RP (Stemetil)”, Presse Médic., 1957, 65, 859.Google Scholar
Broussolle, P., and Dubor, P., “Preliminary appraisal of the clinical effects of a new neuroleptic”, Commun. Congr. Alién. Neurol. Bordeaux, Aug.-Sept., 1956.Google Scholar
Broussolle, et al., “Prochlorperazine in psychiatry. (Experience drawn from 240 courses.)” Presse Médic., 1957, 65, 1628.Google Scholar
Lecomte, G., et al., “Efficacy of prochlorperazine in moderate dosage in states of excitement”, Ann. Med. Psychol., 1957 (May), 50, 922.Google Scholar
McAfoos, L. G., “Prochlorperazine (Compazine) in emotional disturbances”. Dis. Nerv. Syst., 1957, 18, 430.Google Scholar
Settel, E., “Treatment of anxiety and agitation with prochlorperazine in geriatric patients”. J. Amer. Geriat. Soc., 1957, 5, 827.Google Scholar
Vischer, T. J., “Clinical study of prochlorperazine, a new tranquillizer for the treatment of non-hospitalized psychoneurotic patients”, N. Eng. J. Med., 1957, 256, 26.Google Scholar
Wennersten, J. R., “Office treatment of pain and psychic stress: the use of a new tranquillizing agent”, Clin. Med., 1956, 3, 1179.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.